Health CanadaGeneral Alert
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and blee...
Published: December 20, 2018Recall ID: 58819Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
Additional Source Details
| Field | Value |
|---|---|
| N I D | 58819 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/xarelto-rivaroxaban-increase-all-cause-mortality-thromboembolic-and-bleeding-events |
| Issue | Product safety |
| Title | XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2018-12-20 |
| Organization | Marketed health products |